CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model (Q85010396)
Jump to navigation
Jump to search
scientific article published on 12 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model |
scientific article published on 12 November 2010 |
Statements
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model (English)
Marguerite Buchanan
Kaushar Jahan
Adriana Aguilar-Mahecha
Louis Gaboury
William J Muller
Yaqoob Alsawafi
Anna A Mourskaia
Peter M Siegel
Ombretta Salvucci
12 November 2010